TY - JOUR
T1 - Correction to
T2 - Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline(Supportive Care in Cancer, (2024), 32, (542), 10.1007/s00520-024-08710-0)
AU - Davis, Mellar P.
AU - Davies, Andrew
AU - McPherson, Mary Lynn
AU - Reddy, Akhila
AU - Paice, Judith A.
AU - Roeland, Eric
AU - Walsh, Declan
AU - Mercadante, Sebastiano
AU - Case, Amy
AU - Arnold, Robert
AU - Satomi, Eriko
AU - Crawford, Gregory
AU - Bruera, Eduardo
AU - Ripamonti, Carla
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024.
PY - 2024/9
Y1 - 2024/9
N2 - There are a couple of minor errors that I missed in Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline: 1. Table 4 Opioid Potency Table 65 You should refer to Wen RY, Atayee RS, and Edmonds KP. A Comparison of Institutional Opioid Equianalgesia Tools: A National Study.J Palliat Med.2022;25(11):1686-1691. 2. Table 6 Morphine to Methadone Conversion.46 3. Therefore, we compared our findings with previously published conversion tables. Wen and colleagues compared opioid potency ranges in 33 conversion tables collected through social media, organizational LISTSERV, and independent inquiries between May and September 2021. Rather than reference 64.
AB - There are a couple of minor errors that I missed in Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline: 1. Table 4 Opioid Potency Table 65 You should refer to Wen RY, Atayee RS, and Edmonds KP. A Comparison of Institutional Opioid Equianalgesia Tools: A National Study.J Palliat Med.2022;25(11):1686-1691. 2. Table 6 Morphine to Methadone Conversion.46 3. Therefore, we compared our findings with previously published conversion tables. Wen and colleagues compared opioid potency ranges in 33 conversion tables collected through social media, organizational LISTSERV, and independent inquiries between May and September 2021. Rather than reference 64.
UR - http://www.scopus.com/inward/record.url?scp=85201738210&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85201738210&partnerID=8YFLogxK
U2 - 10.1007/s00520-024-08820-9
DO - 10.1007/s00520-024-08820-9
M3 - Comment/debate
C2 - 39162866
AN - SCOPUS:85201738210
SN - 0941-4355
VL - 32
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 9
M1 - 596
ER -